Skip to main content Skip to footer
Donate
Washington

Washington

State Facts

2,500

Deaths, or 78.9% of total overdose deaths involved opioids in 2024.¹

1.7 Million

Patients in Washington were dispensed an opioid in 2023.²

34.5

Opioid Prescriptions were written for every 100 persons in Washington in 2023.³

27,355

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$1,130,987,783.38
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Rep. Emily Randall (D-WA-06)

Rep. Emily Randall (D-WA-06)

2025 Introduced Relevant Legislation

HB 1034

Includes both commercial and Medicaid pain parity along with a non-opioid educational component. This legislation requires equitable insurance coverage for FDA-approved non-opioid pain management treatments, prohibiting stricter controls on non-opioids compared to opioids.

Introduced
12/13/2024
Plan Impact
Commercial & Medicaid
Learn More

Voices Letters

HB 1034 Hearing Letter of Support

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Washington State Department of Health (2024). Opioid and Drug Use Data. https://doh.wa.gov/data-and-statistical-reports/washington-tracking-network-wtn/opioids/overdose-dashboard

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf